ZBHZIMMER BIOMET HOLDINGS, INC.
Orthopedic, Prosthetic & Surgical Appliances & Supplies
- Revenue
- $8.2B
- 7.2% YoY
- Operating margin
- 13.3%
- 20% YoY
- EBITDA
- $2.2B
- 3.9% YoY
- Market cap
- —
- Employees
- —
- Net debt / EBITDA
- 2.5×
- $5.4B net debt
- AI in 10-K
- —
Red flags 1 of 9
- TSR below peersClear—3+ of last 5 years
- High CEO pay despite TSRClear—Median CEO pay ≥ $15M and TSR flag
- Active 13DClear0 filingsActive-intent 13D in 18 months
- Net insider sellingClear$0 netNet sales over $10M in 12 months
- Earnings not backed by cashClear241% of net incomeCash flow under 80% of net income
- Dilutive SBCClear1% of revenueOver 10% of revenue
- Payouts exceed cash flowClear40% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyFired44% of assetsOver 40% of assets
- Shareholder dissentClear—Any vote under 80% support
Financials
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|---|---|
| Revenue | $6.8B | $6.9B | $7.4B | $7.7B | $8.2B | 7.2% |
| Operating income | $860M | $696M | $1.3B | $1.3B | $1.1B | 15% |
| Net income | $402M | $231M | $1.0B | $904M | $705M | 22% |
| Operating cash flow | $1.5B | $1.4B | $1.6B | $1.5B | $1.7B | 13% |
| Capex | $144M | $188M | $291M | $204M | $225M | 10% |
| Stock-based comp | $76M | $105M | $100M | $101M | $90M | 11% |
| Buybacks | — | $126M | $692M | $868M | $487M | 44% |
| Dividends | $200M | $201M | $201M | $196M | $190M | 2.9% |
Deal filings
None.
13D filers
None on file.
Insider trading
- Open-market buys, 12 mo
- $0 · 0
- Open-market sells, 12 mo
- $824K · 2
- Net
- −$824K
Pay vs performance
No pay-versus-performance disclosure yet.